Histology of the pleural rind at [ 18 F]FDG PET/CT hot and cold spots in mesothelioma patients after talc pleurodesis and neoadjuvant chemotherapy

December 8, 2021 | Comments Off on Histology of the pleural rind at [ 18 F]FDG PET/CT hot and cold spots in mesothelioma patients after talc pleurodesis and neoadjuvant chemotherapy

Pathology, Research and Practice 2021 December [Link] Alex Soltermann, Isabelle Opitz, Irene A Burger Abstract The role of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG PET/CT) in evaluating induction chemotherapy in…

Highly sensitive quantification of pemetrexed in human plasma using UPLC-MS/MS to support microdosing studies

December 7, 2021 | Comments Off on Highly sensitive quantification of pemetrexed in human plasma using UPLC-MS/MS to support microdosing studies

Biomedical Chromatography 2021 November 5 [Link] Eleonora W J van Ewijk-Beneken Kolmer, Marga J A Teulen, Rene J Boosman, Nikki de Rouw, Jacobus A Burgers, Rob Ter Heine Abstract Pemetrexed…

Anticancer agent α-sulfoquinovosyl-acylpropanediol enhances the radiosensitivity of human malignant mesothelioma in nude mouse models

December 6, 2021 | Comments Off on Anticancer agent α-sulfoquinovosyl-acylpropanediol enhances the radiosensitivity of human malignant mesothelioma in nude mouse models

Journal of Radiation Research 2021 November 5 [Link] Eiko Inamasu, Tomoshi Tsuchiya, Motohiro Yamauchi, Kodai Nishi, Katsuya Matsuda, Fumio Sugawara, Kengo Sakaguchi, Ryoichi Mori, Keitaro Matsumoto, Takuro Miyazaki, Go Hatachi,…

The Rarest of the Rare: A Case of BAP1-Mutated Primary Peritoneal Mesothelioma

December 3, 2021 | Comments Off on The Rarest of the Rare: A Case of BAP1-Mutated Primary Peritoneal Mesothelioma

Cureus 2021 September 29 [Link] Aanchal Gupta, Alisa Vasileva, Sukesh Manthri Abstract Malignant mesotheliomas (MM), as described are rare tumors that are mostly associated with occupational exposure to asbestos. They…

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma

December 2, 2021 | Comments Off on JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma

Journal for Immunotherapy of Cancer 2021 October [Link] Yosuke Miyamoto, Toshiyuki Kozuki, Keisuke Aoe, Sae Wada, Daijiro Harada, Michihiro Yoshida, Jun Sakurai, Katsuyuki Hotta, Nobukazu Fujimoto Abstract Background: JME-001 is…

Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study

December 1, 2021 | Comments Off on Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study

Annals of Surgical Oncology 2021 October 28 [Link] Vahan Kepenekian, Julien Péron, Benoit You, Isabelle Bonnefoy, Laurent Villeneuve, Mohammad Alyami, Naoual Bakrin, Pascal Rousset, Nazim Benzerdjeb, Olivier Glehen Abstract Background:…

Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion

November 30, 2021 | Comments Off on Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion

Thoracic Cancer 2021 October 26 [Link] Shu Zhang, Yuan Zhang, Wei Feng, Zhongyue Shi, Huanzhong Shi, Yuhui Zhang Abstract Background: Malignant pleural effusion (MPE) is common in malignant pleural mesothelioma…

Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results-Medicare data

November 29, 2021 | Comments Off on Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results-Medicare data

Cancer Reports 2021 October 26 [Link] Mark D Danese, Melinda Daumont, Esmond Nwokeji, Michelle Gleeson, John R Penrod, Deborah Lubeck Abstract Background: Malignant mesothelioma is a rare neoplasm associated with…

Extracellular Vesicle Enriched miR-625-3p Is Associated with Survival of Malignant Mesothelioma Patients

November 19, 2021 | Comments Off on Extracellular Vesicle Enriched miR-625-3p Is Associated with Survival of Malignant Mesothelioma Patients

Journal of Personalized Medicine 2021 October 9 [Link] Katja Goričar, Marija Holcar, Nina Mavec, Viljem Kovač, Metka Lenassi, Vita Dolžan Abstract Malignant mesothelioma (MM) is characterized by poor prognosis and…

Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma

November 18, 2021 | Comments Off on Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma

Cells 2021 September 22 [Link] Hitomi Sudo, Atsushi B Tsuji, Aya Sugyo, Mika K Kaneko, Yukinari Kato, Kotaro Nagatsu, Hisashi Suzuki, Tatsuya Higashi Abstract The prognosis of advanced mesothelioma is…

Categories